173 related articles for article (PubMed ID: 29752210)
41. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
42. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
43. Extranodal lymphomas in the public health system in Chile: Analysis of 1251 patients from the National Adult Cancer Program.
Peña C; Russo M; Martinez V; Cabrera ME
Hematol Oncol; 2019 Feb; 37(1):47-53. PubMed ID: 30117170
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
46. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
47. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
48. [Survival and Prognosis of Patients with Nasal NK/T-Cell Lymphoma].
Xie DN; Li YH; Chen XJ; Lu SM; Hu T; Han YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):507-511. PubMed ID: 32319387
[TBL] [Abstract][Full Text] [Related]
49. Gastrointestinal Lymphoma in Southwest China: Subtype Distribution of 1,010 Cases Using the WHO (2008) Classification in a Single Institution.
Ding W; Zhao S; Wang J; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
Acta Haematol; 2016; 135(1):21-8. PubMed ID: 26303279
[TBL] [Abstract][Full Text] [Related]
50. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
51. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.
Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS
Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879
[TBL] [Abstract][Full Text] [Related]
52. Primary ophthalmic natural killer/T-cell lymphoma: A population-based study.
Loap P; Kirova Y; Dendale R
Bull Cancer; 2024 Mar; 111(3):310-313. PubMed ID: 38199833
[TBL] [Abstract][Full Text] [Related]
53. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
55. Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?
Wu CC; Takahashi E; Asano N; Miyata-Takata T; Takata K; Furukawa K; Elsayed AA; Hu LM; Satou A; Kohno K; Kosugi H; Ohashi K; Kinoshita T; Nakamura S; Kato S
Hum Pathol; 2017 Oct; 68():61-68. PubMed ID: 28873353
[TBL] [Abstract][Full Text] [Related]
56. Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients.
Su C; Nguyen KA; Bai HX; Balaji D; Cao Y; Karakousis G; Zhang PJ; Zhang G; Xiao R
Leuk Lymphoma; 2018 Jun; 59(6):1406-1412. PubMed ID: 28980517
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract.
Fang H; Jin J; Wang WH; Wang SL; Zhou LQ; Li YX
Leuk Lymphoma; 2014 Aug; 55(8):1832-7. PubMed ID: 24144309
[TBL] [Abstract][Full Text] [Related]
58. Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type.
Yamazaki E; Tomita N; Koyama S; Ogusa E; Ishii Y; Takahashi H; Miyashita K; Matsuura S; Tachibana T; Takasaki H; Takemura S; Fujimaki K; Sakai R; Fujisawa S; Ishigatsubo Y
Med Oncol; 2014 Sep; 31(9):149. PubMed ID: 25108598
[TBL] [Abstract][Full Text] [Related]
59. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
[TBL] [Abstract][Full Text] [Related]
60. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
